Education
About Us
Working with TipRanks
Follow Us
Geovax Labs, Inc. (GOVX)
:GOVX
Earnings Data
Report Date
Nov 06, 2025TBA (Confirmed)
Period Ending
2025 (Q3)Consensus EPS Forecast
―Last Year’s EPS
-0.91Same Quarter Last Year
Strong Buy
Based on 3 Analysts Ratings
Earnings Call Summary
Q2 2025
Earnings Call Date:Aug 06, 2025|
% Change Since: ―|
Earnings Call Sentiment|Neutral
The earnings call presented a mixed picture. Significant achievements included the EMA's expedited path for GEO-MVA, increased revenues, and progress in vaccine development. However, these were offset by the termination of the BARDA contract, increased expenses, and continued net losses, leading to balanced highlights and lowlights.Company Guidance -
Q3 2025
EMA Guidance for GEO-MVA
GeoVax received guidance from the European Medicines Agency (EMA) for an expedited development path for GEO-MVA, allowing them to bypass Phase I and II trials and proceed directly to a Phase III immunobridging trial.
Increased Revenue
GeoVax reported revenues of $2.5 million for the first six months of 2025, a significant increase from $301,000 in 2024.
GEO-CMO4S1 Progress
The company is advancing its GEO-CMO4S1 vaccine for immunocompromised patients, with multiple ongoing clinical trials and presentations at major conferences.
Gedeptin Phase II Study
Plans are underway for a Phase II Gedeptin trial in head and neck cancer, with protocol modifications based on recent KEYNOTE-689 study results.
Follow-on Public Offering
GeoVax concluded a follow-on public offering in July, raising almost $6 million in net proceeds, bolstering cash balances.
GOVX Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
GOVX Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 01, 2025 | $0.99 | $1.01 | +2.02% |
Mar 27, 2025 | $1.27 | $1.11 | -12.60% |
Nov 12, 2024 | $3.25 | $2.70 | -16.92% |
Aug 06, 2024 | $1.80 | $1.78 | -1.11% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Geovax Labs, Inc. (GOVX) report earnings?
Geovax Labs, Inc. (GOVX) is schdueled to report earning on Nov 06, 2025, TBA (Confirmed).
What is Geovax Labs, Inc. (GOVX) earnings time?
Geovax Labs, Inc. (GOVX) earnings time is at Nov 06, 2025, TBA (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is GOVX EPS forecast?
Currently, no data Available